Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Scholar Rock Holding Corp (SRRK)

Scholar Rock Holding Corp (SRRK)
30.47 +1.54 (+5.32%) 13:02 ET [NASDAQ]
30.40 x 6 30.47 x 6
Realtime by (Cboe BZX)
30.40 x 6 30.47 x 6
Realtime 29.16 +0.23 (+0.80%) 09:30 ET
Quote Overview for Tue, Apr 15th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
29.15
Day High
31.06
Open 29.15
Previous Close 28.93 28.93
Volume 746,389 746,389
Avg Vol 1,515,286 1,515,286
Stochastic %K 56.77% 56.77%
Weighted Alpha -30.91 -30.91
5-Day Change +5.99 (+24.48%) +5.99 (+24.48%)
52-Week Range 6.76 - 46.98 6.76 - 46.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,739,006
  • Shares Outstanding, K 94,677
  • Annual Sales, $ 0 K
  • Annual Income, $ -246,290 K
  • EBIT $ -252 M
  • EBITDA $ -255 M
  • 60-Month Beta 0.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.11

Options Overview Details

View History
  • Implied Volatility 108.09% ( -1.47%)
  • Historical Volatility 72.69%
  • IV Percentile 73%
  • IV Rank 44.40%
  • IV High 200.88% on 09/24/24
  • IV Low 33.99% on 08/01/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 161
  • Volume Avg (30-Day) 263
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 14,141
  • Open Int (30-Day) 12,859

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.63
  • Number of Estimates 8
  • High Estimate -0.56
  • Low Estimate -0.71
  • Prior Year -0.59
  • Growth Rate Est. (year over year) -6.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.71 +34.13%
on 04/09/25
Period Open: 34.60
35.21 -13.49%
on 03/17/25
-4.14 (-11.97%)
since 03/14/25
3-Month
22.71 +34.13%
on 04/09/25
Period Open: 44.32
46.98 -35.16%
on 01/23/25
-13.86 (-31.27%)
since 01/15/25
52-Week
6.76 +350.59%
on 10/03/24
Period Open: 13.33
46.98 -35.16%
on 01/23/25
+17.13 (+128.51%)
since 04/15/24

Most Recent Stories

More News
Biohaven’s SMA Trial Miss Bolsters Scholar Rock Stock: Analysts Give Verdicts, Retail Watches Closely

Last month, Scholar Rock achieved the primary endpoint in the company's own Phase 3 trial of apitegromab in SMA patients.

BHVN : 18.15 (-1.94%)
VTI : 264.10 (-0.02%)
SRRK : 30.46 (+5.29%)
IWM : 186.92 (+0.21%)
XBI : 75.71 (-1.08%)
Here's Why Everybody's Talking About Scholar Rock Right Now

Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.

SRRK : 30.46 (+5.29%)
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and safety of its investigational muscle-targeted...

BHVN : 18.15 (-1.94%)
ANIP : 68.90 (+0.26%)
CPRX : 22.98 (+0.79%)
SRRK : 30.46 (+5.29%)
S&P 500 Posts a Record High on Optimism the Fed Can Achieve a Soft Landing

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. Stock indexes...

AAPL : 201.63 (-0.44%)
MRO : 28.55 (-1.28%)
$IUXX : 18,927.62 (+0.70%)
ZNM25 : 111-030 (+0.31%)
OXY : 37.98 (+0.21%)
TSLA : 252.76 (+0.16%)
WBA : 10.85 (-0.55%)
VLO : 108.80 (-1.39%)
$DOWI : 40,592.26 (+0.17%)
SPY : 539.11 (unch)
DIA : 405.10 (-0.08%)
CC : 11.26 (-2.26%)
Stocks Pressured by Hawkish Statement by a Fed Official

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. Stock indexes this...

CC : 11.26 (-2.26%)
KMB : 141.81 (-0.53%)
META : 524.54 (-1.31%)
AAPL : 201.63 (-0.44%)
OMC : 77.25 (+0.93%)
SNOW : 145.90 (+0.93%)
$SPX : 5,427.08 (+0.39%)
MLKN : 16.02 (-1.60%)
EL : 53.99 (-2.88%)
MOH : 335.42 (-3.77%)
$IUXX : 18,927.62 (+0.70%)
CCL : 17.90 (+0.45%)
Stocks See Support from Improved Soft-Landing Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.08%. Stock indexes this morning...

CC : 11.26 (-2.26%)
META : 524.54 (-1.31%)
AAPL : 201.63 (-0.44%)
OMC : 77.25 (+0.93%)
SNOW : 145.90 (+0.93%)
$SPX : 5,427.08 (+0.39%)
MLKN : 16.02 (-1.60%)
EL : 53.99 (-2.88%)
$IUXX : 18,927.62 (+0.70%)
QQQ : 458.23 (+0.16%)
ZNM25 : 111-030 (+0.31%)
RH : 161.93 (-1.13%)
Why Scholar Rock Holding Stock Soared Today

The market celebrated Scholar Rock's upsized stock offering and plans to advance development of a new obesity treatment. Here's what investors need to know.

SRRK : 30.46 (+5.29%)
Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference

Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced today it...

SRRK : 30.46 (+5.29%)
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; “The Company”), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role,...

SRRK : 30.46 (+5.29%)
Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that...

SRRK : 30.46 (+5.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge,...

See More

Key Turning Points

3rd Resistance Point 30.91
2nd Resistance Point 30.25
1st Resistance Point 29.59
Last Price 30.46
1st Support Level 28.27
2nd Support Level 27.61
3rd Support Level 26.94

See More

52-Week High 46.98
Fibonacci 61.8% 31.62
Last Price 30.46
Fibonacci 50% 26.87
Fibonacci 38.2% 22.12
52-Week Low 6.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro